Cathie Wood’s ARK Invest Adjusts Portfolio with Key Tech and Biotech Moves

ARK Invest, led by Cathie Wood, made significant portfolio adjustments on September 10, emphasizing growth in semiconductor and fintech sectors. The firm allocated $9.5 million to Synopsys (SNPS), a chip design software leader, signaling confidence in AI-driven demand. Swedish fintech Klarna (KLAR) and cloud data firm Rubrik (RBRK) attracted $9 million and $6.6 million in fresh investments, respectively.

Biotech saw aggressive positioning, with Prime Medicine (PRME) and Twist Bioscience (TWST) receiving nearly $950,710 and $5.6 million in follow-on buys. The genomic and synthetic biology plays underscore Wood's thematic focus on disruptive innovation. Meanwhile, ARK trimmed exposure to consumer-facing names like Shopify and Roblox, reflecting a pivot toward infrastructure enablers of digital transformation.